autologous ex-vivo expanded effector cells
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00439465)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous ex-vivo expanded effector cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00439465 | Phase 2 | Jan 1, 2007 | Dartmouth University, The Leukemia and Lymphoma Society |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dartmouth University | Academic/Hospital | 1 | 1 | 1 | 2007 |
| The Leukemia and Lymphoma Society | Academic/Hospital | 1 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1